LIMK2 and Alzheimer disease: Injection of streptozotocin in rats led to inhibition of the neuronal insulin receptor and induced an AD-like phenotype and these effects were associated with increased phosphorylated LIMK2, degeneration of synaptic structures, and memory deficits [159].